Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.39
Delayed Data
As of Feb 16
 +0.01 / +0.42%
Today’s Change
2.00
Today|||52-Week Range
7.15
-0.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-25.6M-35.3M-148.3M-169.6M
 
 
 
 
 
Depreciation8.7M33.0M94.7M86.2M
 
 
 
 
 
Total Other Cash Flow21.3M12.5M36.4M44.3M
 
 
 
 
 
Funds From Operations-18.2M-1.6M-10.5M-39.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-11.7M-10.5M4.2M-22.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-6.5M8.9M-14.7M-16.5M
 
 
 
 
 
 
InvestingDecrease In Investments4.6M0.000.000.00
 
 
Capital Expenditures-527.5K-1.2M-1.2M-984.0K
 
 
 
 
 
Fixed Asset Disposal19.6M1.4M0.00--
 
 
 
Net Assets From Acquisitions -309.6K-255.0M-88.0M-583.0K
 
 
 
 
 
Other Investing - Sources0.004.9M4.9M0.00
 
 
 
Net Cash Flow Investing23.4M-249.9M-84.3M-1.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.00270.9M132.3M0.00
 
 
 
Long Term Debt Reduction-25.3M-9.6M-10.1M-21.5M
 
 
 
 
 
Net Proceeds Stock Sale261.4K2.1M395.0K19.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing2.9M404.0K0.00--
 
 
 
Other Uses - Financing2.1M3.6M2.3M23.0K
 
 
 
 
 
Net Cash Flow - Financing-24.2M260.2M120.4M-1.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash-7.4M19.2M21.3M-19.8M